Cell Expansion Market was valued at USD 17.15 Billion in 2021, and it is expected to reach USD 52.83 Billion by 2029, exhibiting a CAGR of 15.1% during the forecast period (2022-2029)Cell Expansion Market Overview:
The Global Cell Expansion Market is segmented by product, cell type, application, and end-users. Based on product, the market is segmented into consumables (reagents, media, sera, disposables - tissue culture flasks, bioreactor accessories, other disposables: pipette tubes, petri plates, centrifuge tubes, cell expansion bags, filtration membranes), instruments (cell expansion supporting equipment- flow cytometers, centrifuges, cell counters, other supporting equipment), bioreactors (microcarrier bioreactors- microcarrier-based anchorage-dependent bioreactors, suspension-based anchorage-independent bioreactors, perfusion/hollow fibre bioreactors), and automated cell expansion systems. Based on cell type, the market is segmented into human cells (stem cells, adult stem cells- induced pluripotent stem cells, embryonic stem cells, differentiated cells) and animal cells. Based on application, the market is segmented into regenerative medicine and stem cell research, cancer and cell-based research, and other applications (clinical studies, toxicology studies). Based on end-users, the market is segmented into research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end-users (hospitals and diagnostic laboratories). Based on region, the market is segmented into North America, Asia Pacific, Europe, Middle East & Africa, and South America.To know about the Research Methodology :- Request Free Sample Report COVID-19 Impact on Cell Expansion Market Mesenchymal stromal cells (MSCs), in particular, present a viable method for reducing the negative consequences of the COVID-19 infection. Cell-based methods. In COVID-19 patients, this treatment has been demonstrated to improve tissue healing as well as decrease the production of pro-inflammatory cytokines. Since the start of the COVID-19 pandemic, 27 clinical studies of MSC-based cell therapy techniques have started in China, along with an increasing number of university and industrial trials overseas, according to the WHO ICTRP and the NIH ClinicalTrials.gov databases. One of the main uses of cell expansion is in stem cell and regenerative medicine research. This is a key sign of market expansion since the COVID-19 trial indicates that stem cell-based medicines have a lot of potentials. Additionally, numerous cell growth tools (like bioreactors) and supplies (such as cell culture medium) are employed in COVID-19 research. Consequently, the COVID-19 pandemic has had a favourable effect on the cell expansion business.
Cell Expansion Market Dynamics
Increasing incidence of chronic diseases: When developing new medications to treat ailments, cell expansion is employed. It is employed in the creation of antibiotics, medicines, treatments, and vaccines. There is a pressing need for in-depth study to generate novel treatment alternatives due to the increasing prevalence of illnesses like cancer and diabetes. The International Diabetes Federation (IDF) estimates that 629 million people will have diabetes by the year 2045, up from an estimated 425 million in 2017. In 2018, there were 9.6 million fatalities due to cancer, which has overtaken all other causes of mortality in the world. GLOBOCAN predicts that by 2040, there would be over 30 million new instances of cancer, up from 18 million in 2018. The growth in the prevalence of these diseases has resulted in a need to conduct extensive research for their diagnosis and treatment; cell expansion forms an important part of this research. Emerging markets: The cell expansion market is estimated to grow mostly in emerging markets. In recent years, the biotechnology and pharmaceutical sectors have seen substantial growth in nations like India, Brazil, and China. During the forecast period, this trend is expected to continue. The biotechnology business in India is estimated to grow from USD 11 billion in 2016 to USD 100 billion by 2025, at a pace of 30.46 percent, according to the India Brand Equity Foundation (IBEF). The same source predicts that India's pharmaceutical market would grow from USD 36.7 billion in 2016 to USD 55 billion in 2020. The medicines market in Brazil is estimated to rise from USD 25.3 billion in 2016 to USD 29.9 billion by 2021. (Source: Advantage Business Marketing). The need for cell expansion products for R&D and pharmaceutical product production is estimated to grow as the biotechnology and pharmaceutical sectors in these nations expand.Ethical concerns regarding research in cell biology: Animal and human cells are utilised in gene therapy studies that include the recombination of genes and stem cell research treatments, making the use of both species necessary for study in cell biology. These cells are also utilised to investigate the toxicity and pharmacokinetics of medications that may be harmful to both people and animals in vivo. Additionally, human embryos are frequently destroyed in stem cell research trials that employ them for medicinal purposes. Strict rules have been developed by ethical authorities in several nations across the world to oversee these activities. Cell biology research is subject to strict regulations that have been put in place by organisations including the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others. Cell biology research is being severely constrained in many nations around the world due to these ethical issues and regulations on the use of cells for study. In consequence, it is expected that this would limit the market for cell expansion's expansion.
Cell Expansion Market Segment Analysis
By product, the consumables segment accounted for the largest share of the cell expansion market in 2021. Based on the product, the cell expansion market is segmented into consumables and instruments. The consumables segment is further segmented into reagents, media, sera, and disposables, while instruments are segmented into cell expansion supporting equipment, bioreactors, and automated cell expansion systems. In 2021, due to the growing manufacturing of biologics in the biopharmaceutical and biotechnology sectors, consumables held the majority of the market share for cell expansion products.By cell type, the human cells segment accounted for the largest share of the cell expansion market in 2021. Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. In 2021, the human cells segment accounted for the larger share of the cell expansion market, majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer. By application, the regenerative medicine and stem cell research segment accounted for the largest share of the cell expansion market in 2021. Based on application, the cell expansion market has been segmented into regenerative medicine and stem cell research, cancer & cell-based research, and others. The regenerative medicine and stem cell research segment accounted for the largest market share in 2021 due to the increased funding for regenerative medicine and stem cell research.
Based on end-user, the market is segmented into research institutes, biotechnology and biopharmaceutical companies, cell banks, and end-users (hospitals and diagnostic laboratories). Biotechnology & biopharmaceutical companies segment held the largest share of 50 % in 2021 and will expand further at a significant growth rate. One of the main causes of the large share of biopharmaceutical businesses is the growing potential of cell-based medicines in the healthcare sector. For instance, with ongoing advancements in injectable cell delivery methods for a variety of therapeutic applications, cellular-based treatments have greatly increased in popularity in regenerative medicine. Companies in the pharmaceutical and biopharmaceutical industries are also making acquisitions to diversify their product offerings. For example, in December 2019, Sartorius AG and Biological Industries, a producer of cell culture medium in Israel, agreed to split 50 percent of the company. With this acquisition, Sartorius's selection of cell culture medium was widened, with a focus on cellular and gene therapies, regenerative medicine, and other cutting-edge treatments.
Cell Expansion Market Regional Insights
North America accounted for the largest share of 43.1% in 2021. Rising cancer incidence, increasing government funding, increasing stem cell therapy research activities, and growing public awareness of cutting-edge treatment options, rising geriatric population, and the significant presence of industry players in the region all contribute to the sector's significant market share. Due to increased government financing efforts that have sped up the production of stem cells and the development of regenerative medicine and cellular therapy products, the area will maintain its leadership position over the next years. This in turn fuels this region's desire for cell expansion platforms. For instance, the Southwest Research Institute (SwRI) received USD 5.3 million in financing from the FDA and the Medical Technology Enterprise Consortium (MTEC) in October 2019. (U.S.). The SwRI invested these funds to propagate cells for the development of personalized regenerative medicine. Such investments boost the revenue generation in this region. Due to increased efforts made by several local pharmaceutical and biotechnology businesses to develop and market their cellular treatments, Asia Pacific is expected to witness the fastest growth during the forecast period. Stempeutics Research Pvt. Ltd., an Indian business, joined up with Kemwell Biopharma in July 2019 to commercialise Stempeucel, a stem cell-based medicine. Small- and mid-sized businesses might expect increased product sales as a result of these partnerships.
Cell Expansion Market Scope: Inquire before buying
Global Cell Expansion Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US 17.15 Bn Forecast Period 2022 to 2029 CAGR: 15.1 % Market Size in 2029: US 52.83 Bn. Segments Covered: by Product • Consumables o Reagents o Media o Sera o Disposables Tissue Culture Flasks Bioreactor Accessories Other Disposables (Pipette Tubes, Petri Plates, Centrifuge Tubes, Cell Expansion Bags, and Filtration Membranes) • Instruments o Cell Expansion Supporting Equipment Flow Cytometers Centrifuges Cell Counters Other Supporting Equipment • Bioreactors o Microcarrier Bioreactors Microcarrier-based anchorage-dependent bioreactors Suspension-based anchorage-independent bioreactors o Perfusion/Hollow Fibre Bioreactors • Automated Cell Expansion Systems by Cell Type • Human Cells o Stem Cells o Adult Stem Cells Induced Pluripotent Stem Cells Embryonic Stem Cells Differentiated Cells • Animal Cells by Application • Regenerative Medicine and Stem Cell Research • Cancer and Cell-based Research • Other Applications (clinical studies, toxicology studies) by End-User • Research Institutes • Biotechnology and Biopharmaceutical Companies • Cell Banks • Other End Users (Hospitals and diagnostic laboratories) Cell Expansion Market by Region:
• North America • Europe • Asia Pacific • The Middle East and Africa • South AmericaCell Expansion Market Key Players:
• Thermo Fisher Scientific • Danaher • Becton • Dickinson and Company • Lonza • Corning • Merck • Miltenyi Biotec • STEMCELL Technologies Inc. • Sartorius Stedim Biotech • Terumo • REPROCELL • iXCells Biotechnologies • Neuromics • G&G technologies • Celltainer Biotech Frequently Asked Questions: 1] What segments are covered in the Global Cell Expansion Market report? Ans. The segments covered in the Cell Expansion Market report are based on Satellite Type, Component, Application, End-Users and Frequency. 2] Which region is expected to hold the highest share in the Global Cell Expansion Market? Ans. The North America region is expected to hold the highest share in the Cell Expansion Market. 3] What is the market size of the Global Cell Expansion Market by 2029? Ans. The market size of the Cell Expansion Market by 2029 is expected to reach USD 52.83 Bn. 4] What is the forecast period for the Global Cell Expansion Market? Ans. The forecast period for the Cell Expansion Market is 2021-2029. 5] What was the market size of the Global Cell Expansion Market in 2021? Ans. The market size of the Cell Expansion Market in 2021 was valued at USD 17.15 Bn.
To know about the Research Methodology :- 
Ethical concerns regarding research in cell biology: Animal and human cells are utilised in gene therapy studies that include the recombination of genes and stem cell research treatments, making the use of both species necessary for study in cell biology. These cells are also utilised to investigate the toxicity and pharmacokinetics of medications that may be harmful to both people and animals in vivo. Additionally, human embryos are frequently destroyed in stem cell research trials that employ them for medicinal purposes. Strict rules have been developed by ethical authorities in several nations across the world to oversee these activities. Cell biology research is subject to strict regulations that have been put in place by organisations including the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others. Cell biology research is being severely constrained in many nations around the world due to these ethical issues and regulations on the use of cells for study. In consequence, it is expected that this would limit the market for cell expansion's expansion.
By cell type, the human cells segment accounted for the largest share of the cell expansion market in 2021. Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. In 2021, the human cells segment accounted for the larger share of the cell expansion market, majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.
By application, the regenerative medicine and stem cell research segment accounted for the largest share of the cell expansion market in 2021. Based on application, the cell expansion market has been segmented into regenerative medicine and stem cell research, cancer & cell-based research, and others. The regenerative medicine and stem cell research segment accounted for the largest market share in 2021 due to the increased funding for regenerative medicine and stem cell research.
Based on end-user, the market is segmented into research institutes, biotechnology and biopharmaceutical companies, cell banks, and end-users (hospitals and diagnostic laboratories). Biotechnology & biopharmaceutical companies segment held the largest share of 50 % in 2021 and will expand further at a significant growth rate. One of the main causes of the large share of biopharmaceutical businesses is the growing potential of cell-based medicines in the healthcare sector. For instance, with ongoing advancements in injectable cell delivery methods for a variety of therapeutic applications, cellular-based treatments have greatly increased in popularity in regenerative medicine. Companies in the pharmaceutical and biopharmaceutical industries are also making acquisitions to diversify their product offerings. For example, in December 2019, Sartorius AG and Biological Industries, a producer of cell culture medium in Israel, agreed to split 50 percent of the company. With this acquisition, Sartorius's selection of cell culture medium was widened, with a focus on cellular and gene therapies, regenerative medicine, and other cutting-edge treatments.
